Mbal Lyulin EAD

The medical center is at the forefront of research in Severe Hypertriglyceridemia, focusing on innovative treatments to manage and reduce elevated triglyceride levels. The center's work in this area is pivotal in developing therapies that can significantly impact patients' cardiovascular health.

• Development of novel lipid-lowering agents
• Impact of triglyceride reduction on cardiovascular risk
• Long-term management strategies for hypertriglyceridemia

Through its research, the center contributes to a deeper understanding of lipid metabolism and its implications for systemic health, offering hope for improved therapeutic outcomes.

Specializing in Rheumatoid Arthritis, the center is dedicated to advancing treatment options that enhance patient quality of life. By exploring both established and emerging therapies, the center aims to provide comprehensive care solutions for this chronic inflammatory disorder.

• Evaluation of long-term safety and efficacy of novel treatments
• Combination therapies for early-stage rheumatoid arthritis
• Biosimilar development and comparative studies

The center's research efforts are instrumental in shaping future therapeutic protocols and improving patient outcomes in rheumatoid arthritis management.

In the field of Osteoporosis, the medical center is committed to pioneering research that addresses bone density loss in postmenopausal women. The center's studies focus on biosimilar development and the comparative efficacy of existing treatments.

• Comparative efficacy of osteoporosis treatments
• Pharmacokinetics and pharmacodynamics of bone health therapies
• Innovations in biosimilar development

By advancing knowledge in bone health, the center plays a crucial role in developing strategies to prevent fractures and improve life quality for those affected by osteoporosis.

The center's research in Progressive Multiple Sclerosis focuses on innovative imaging techniques and therapeutic interventions aimed at slowing disease progression. The center's work is vital in enhancing the understanding of disease mechanisms and treatment efficacy.

• Quantitative MRI analysis for disease progression
• Evaluation of novel therapeutic agents
• Advanced imaging techniques for monitoring treatment response

Through its cutting-edge research, the center contributes to the development of more effective management strategies for progressive forms of multiple sclerosis.